Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Cymeed who wrote (543)	12/18/1997 5:54:00 PM
From: seminole	Read Replies (1) \| Respond to of 887

It is not clear to me where the problem lies. Was the toxic effect the result of the drug or Depofoam delivery system? Short term it might not matter but long term its the delivery system thats important to the company. richard

To: Cymeed who wrote (543)	12/18/1997 6:07:00 PM
From: chirodoc	Respond to of 887

<<<<<<Doc, Depo's cash value is $2.45 and its book value is a little over $3. Tomorrow's price might be near that range. ..........depo was a little more than 10% of my porfolio--i was told years ago to respect the 10% limit. since my price was $13, i will take a 5% portfolio hit assuming we drop to 5-6 range. ........it is depressing but life goes on--now i wish i had put the money in ckfr--it was at $17 when i went depo shopping. .......i hope you were not hurt too badly. i feel sorry for all of the people that invested here in depo--the co. should have been more forthcoming about side effect profile.